Methods for treating bone cancer pain by administering a nerve growth factor antagonist
US7425329B2 · kind B2 · utility
51Cited by
88References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 7, 2005 |
| Grant date | Sep 16, 2008 |
| Priority date | — |
| Expiry date | Apr 23, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.